Evaluating UK national guidance for screening of children for TB: a prospective multi-centre study

Rationale and Objective In order to identify infected contacts of tuberculosis (TB) cases, the UK National Institute for Health and Care Excellence (NICE) recommended the addition of interferon-gamma release assays (IGRA) to the tuberculin skin test (TST) in its 2006 TB guidelines. Treatment for TB...

Full description

Bibliographic Details
Main Authors: Kampmann, B, Seddon, J, Paton, J, Nademi, Z, Keane, D, Williams, B, Williams, A, Liebeschutz, S, Riddell, A, Bernatoniene, J, Patel, S, Martinez, N, McMaster, P, Basu-Roy, R, Welch, S
Format: Journal article
Language:English
Published: American Thoracic Society 2017
_version_ 1797082665269067776
author Kampmann, B
Seddon, J
Paton, J
Nademi, Z
Keane, D
Williams, B
Williams, A
Liebeschutz, S
Riddell, A
Bernatoniene, J
Patel, S
Martinez, N
McMaster, P
Basu-Roy, R
Welch, S
author_facet Kampmann, B
Seddon, J
Paton, J
Nademi, Z
Keane, D
Williams, B
Williams, A
Liebeschutz, S
Riddell, A
Bernatoniene, J
Patel, S
Martinez, N
McMaster, P
Basu-Roy, R
Welch, S
author_sort Kampmann, B
collection OXFORD
description Rationale and Objective In order to identify infected contacts of tuberculosis (TB) cases, the UK National Institute for Health and Care Excellence (NICE) recommended the addition of interferon-gamma release assays (IGRA) to the tuberculin skin test (TST) in its 2006 TB guidelines. Treatment for TB infection was no longer recommended for children screened TST-positive but IGRA-negative. We carried out a cohort study to evaluate the risk of TB disease in this group. Methods Children exposed to an infectious case of TB in their household were recruited from 11 paediatric TB clinics. TST and IGRA were carried out at baseline, IGRA repeated at 8 weeks and TST repeated if initially negative. Children were treated according to 2006 NICE guidelines and followed for 24 months. Measurements and Main Results Of 431 recruited children 392 completed the study. We diagnosed 48 (12.2%) cases of prevalent TB disease, 105 (26.8%) with TB infection and 239 (60.9%) without TB infection or disease. 18 children aged two years and above had a positive TST but persistently negative IGRA. None received TB infection treatment and none developed TB disease. 90 (26.1%) children qualified for TB infection treatment according to 2006 NICE guidelines. In contrast, 147 (42.7%) children would have qualified under revised NICE guidance, issued in 2016. Conclusions In this low prevalence setting we saw no incident cases of TB disease in children who were TST-positive but IGRA-negative and did not receive treatment for TB infection. Following the latest NICE guidance, significantly more children will require medication.
first_indexed 2024-03-07T01:30:58Z
format Journal article
id oxford-uuid:9394c513-87a0-437b-85f9-116399d38e05
institution University of Oxford
language English
last_indexed 2024-03-07T01:30:58Z
publishDate 2017
publisher American Thoracic Society
record_format dspace
spelling oxford-uuid:9394c513-87a0-437b-85f9-116399d38e052022-03-26T23:33:17ZEvaluating UK national guidance for screening of children for TB: a prospective multi-centre studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:9394c513-87a0-437b-85f9-116399d38e05EnglishSymplectic Elements at OxfordAmerican Thoracic Society2017Kampmann, BSeddon, JPaton, JNademi, ZKeane, DWilliams, BWilliams, ALiebeschutz, SRiddell, ABernatoniene, JPatel, SMartinez, NMcMaster, PBasu-Roy, RWelch, SRationale and Objective In order to identify infected contacts of tuberculosis (TB) cases, the UK National Institute for Health and Care Excellence (NICE) recommended the addition of interferon-gamma release assays (IGRA) to the tuberculin skin test (TST) in its 2006 TB guidelines. Treatment for TB infection was no longer recommended for children screened TST-positive but IGRA-negative. We carried out a cohort study to evaluate the risk of TB disease in this group. Methods Children exposed to an infectious case of TB in their household were recruited from 11 paediatric TB clinics. TST and IGRA were carried out at baseline, IGRA repeated at 8 weeks and TST repeated if initially negative. Children were treated according to 2006 NICE guidelines and followed for 24 months. Measurements and Main Results Of 431 recruited children 392 completed the study. We diagnosed 48 (12.2%) cases of prevalent TB disease, 105 (26.8%) with TB infection and 239 (60.9%) without TB infection or disease. 18 children aged two years and above had a positive TST but persistently negative IGRA. None received TB infection treatment and none developed TB disease. 90 (26.1%) children qualified for TB infection treatment according to 2006 NICE guidelines. In contrast, 147 (42.7%) children would have qualified under revised NICE guidance, issued in 2016. Conclusions In this low prevalence setting we saw no incident cases of TB disease in children who were TST-positive but IGRA-negative and did not receive treatment for TB infection. Following the latest NICE guidance, significantly more children will require medication.
spellingShingle Kampmann, B
Seddon, J
Paton, J
Nademi, Z
Keane, D
Williams, B
Williams, A
Liebeschutz, S
Riddell, A
Bernatoniene, J
Patel, S
Martinez, N
McMaster, P
Basu-Roy, R
Welch, S
Evaluating UK national guidance for screening of children for TB: a prospective multi-centre study
title Evaluating UK national guidance for screening of children for TB: a prospective multi-centre study
title_full Evaluating UK national guidance for screening of children for TB: a prospective multi-centre study
title_fullStr Evaluating UK national guidance for screening of children for TB: a prospective multi-centre study
title_full_unstemmed Evaluating UK national guidance for screening of children for TB: a prospective multi-centre study
title_short Evaluating UK national guidance for screening of children for TB: a prospective multi-centre study
title_sort evaluating uk national guidance for screening of children for tb a prospective multi centre study
work_keys_str_mv AT kampmannb evaluatinguknationalguidanceforscreeningofchildrenfortbaprospectivemulticentrestudy
AT seddonj evaluatinguknationalguidanceforscreeningofchildrenfortbaprospectivemulticentrestudy
AT patonj evaluatinguknationalguidanceforscreeningofchildrenfortbaprospectivemulticentrestudy
AT nademiz evaluatinguknationalguidanceforscreeningofchildrenfortbaprospectivemulticentrestudy
AT keaned evaluatinguknationalguidanceforscreeningofchildrenfortbaprospectivemulticentrestudy
AT williamsb evaluatinguknationalguidanceforscreeningofchildrenfortbaprospectivemulticentrestudy
AT williamsa evaluatinguknationalguidanceforscreeningofchildrenfortbaprospectivemulticentrestudy
AT liebeschutzs evaluatinguknationalguidanceforscreeningofchildrenfortbaprospectivemulticentrestudy
AT riddella evaluatinguknationalguidanceforscreeningofchildrenfortbaprospectivemulticentrestudy
AT bernatonienej evaluatinguknationalguidanceforscreeningofchildrenfortbaprospectivemulticentrestudy
AT patels evaluatinguknationalguidanceforscreeningofchildrenfortbaprospectivemulticentrestudy
AT martinezn evaluatinguknationalguidanceforscreeningofchildrenfortbaprospectivemulticentrestudy
AT mcmasterp evaluatinguknationalguidanceforscreeningofchildrenfortbaprospectivemulticentrestudy
AT basuroyr evaluatinguknationalguidanceforscreeningofchildrenfortbaprospectivemulticentrestudy
AT welchs evaluatinguknationalguidanceforscreeningofchildrenfortbaprospectivemulticentrestudy